Abstract
A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cherington M. Guanidine and germine in Eaton-Lambert syndrome. Neurology. 1976 Oct;26(10):944–946. doi: 10.1212/wnl.26.10.944. [DOI] [PubMed] [Google Scholar]
- Elmqvist D., Lambert E. H. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc. 1968 Oct;43(10):689–713. [PubMed] [Google Scholar]
- Henriksson K. G., Nilsson O., Rosén I., Schiller H. H. Clinical, neurophysiological and morphological findings in Eaton Lambert syndrome. Acta Neurol Scand. 1977 Aug;56(2):117–140. doi: 10.1111/j.1600-0404.1977.tb01417.x. [DOI] [PubMed] [Google Scholar]
- Lambert E. H. Defects of neuromuscular transmission in syndromes other than myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):367–384. doi: 10.1111/j.1749-6632.1966.tb45484.x. [DOI] [PubMed] [Google Scholar]
- Lemeignan M. Abord pharmacologique de l'étude du mécanisme de l'action convulsivante de l'amino-4 pyridine. Therapie. 1971 Sep-Oct;26(5):927–940. [PubMed] [Google Scholar]
- Lundh H., Leander S., Thesleff S. Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine. J Neurol Sci. 1977 May;32(1):29–43. doi: 10.1016/0022-510x(77)90037-5. [DOI] [PubMed] [Google Scholar]
- Lundh H., Thesleff S. The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals. Eur J Pharmacol. 1977 Apr 21;42(4):411–412. doi: 10.1016/0014-2999(77)90176-5. [DOI] [PubMed] [Google Scholar]